Cohort Follow-up of Epidemic and Neuroimaging for Patients During the 1st Wave of the COVID-19 in China

NCT05745805 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 600

Last updated 2023-02-27

No results posted yet for this study

Summary

Our main objective is to analyze the development of physical impact, mental health and blood profile over follow-up time during the 1st wave of the COVID-19. Besides, we aim to establish a database of post-COVID-19 based on simultaneous cortico-spinal magnetic resonance imaging data to identify high-risk patients with long COVID and prevent the neurological symptoms evolution, optimize the tactics of management in China.

Conditions

  • COVID-19
  • Post-COVID-19 Syndrome
  • Acute COVID-19
  • Post-Acute COVID-19

Interventions

DEVICE

Simultaneous cortico-spinal magnetic resonance imaging, Serum

Simultaneous cortico-spinal magnetic resonance imaging data were collected in a strong magnetic field and collected the serum of participants.

Sponsors & Collaborators

  • Nuclear 215 Hospital of Shaanxi Province

    collaborator UNKNOWN
  • Yanan Traditional Chinese Medicine Hospital

    collaborator UNKNOWN
  • Shangluo Central Hospital

    collaborator OTHER
  • Xian QinHuang Hospital

    collaborator UNKNOWN
  • Yulin No.2 Hospital

    collaborator OTHER
  • Hanzhong Central Hospital

    collaborator OTHER
  • Ankang Central Hospital

    collaborator OTHER
  • Baoji High-tech Hospital

    collaborator UNKNOWN
  • First Affiliated Hospital Xi'an Jiaotong University

    lead OTHER

Principal Investigators

  • Ming Zhang, PhD · First Affiliated Hospital of Xian Jiaotong University

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-01-12
Primary Completion
2026-06-12
Completion
2026-09-12

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05745805 on ClinicalTrials.gov